دورية أكاديمية
Phase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations
| العنوان: | Phase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations |
|---|---|
| المؤلفون: | Hong, David S., Cappuzzo, Federico, Chul Cho, Byoung, Dowlati, Afshin, Hussein, Maen, Kim, Dong-Wan, Percent, Ivor, Christensen, James G., Morin, Josée, Potvin, Diane, Faltaos, Demiana, Tassell, Vanessa, Der-Torossian, Hirak, Chao, Richard |
| المصدر: | In Lung Cancer April 2024 190 |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 01695002 |
|---|---|
| DOI: | 10.1016/j.lungcan.2024.107512 |